Shashank Sama
( out of 25 reviews )

Shashank Sama, MBBS

Languages spoken: English

  • Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    National Board of Medical Examiners

    Patient Rating

    4.9 /5
    ( out of 25 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    January 24, 2025
    HUNTSMAN CANCER CENTER

    Was so happy to meet him and extremely impressed!

    October 19, 2024
    HUNTSMAN CANCER CENTER

    Very thorough and understood my need to have Chemo done at UBMC in Roosevelt, UT due to logistics and weather concerns.

    July 19, 2024
    HUNTSMAN CANCER CENTER

    He was very good. If I didn't want care closer to home I would be pleased to have him as my provider.

    July 05, 2024
    HUNTSMAN CANCER CENTER

    He is a wizard! Anticipates questions and provides concise understandable answers to ANY concerns! Extraordinarily considerate!

    May 24, 2024
    HUNTSMAN CANCER CENTER

    Great listener, superb question answerer, responds as promised, and considers patient perspective!

    January 05, 2024
    HUNTSMAN CANCER CENTER

    Very detailed and knowledgeable

  • Board Certification and Academic Information

    Academic Departments Internal Medicine -Assistant Professor (Clinical)
    Academic Divisions Oncology
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    National Board of Medical Examiners

    Education history

    Fellowship Hematology & Medical Oncology - University of Utah School of Medicine, Huntsman Cancer Institute Chief Fellow
    Fellowship Hematology & Medical Oncology - University of Utah School of Medicine, Huntsman Cancer Institute Fellow
    Residency Internal Medicine - University of Connecticut School of Medicine Resident
    Internship Internal Medicine - University of Connecticut School of Medicine Intern
    Professional Medical Medicine, Surgery - Osmania Medical College M.B.B.S.

    Selected Publications

    Journal Article

    1. Smith JT, Sama S, Florou V, Nevala-Plagemann C, Garrido-Laguna I (2023). Durable response to first-line PARP inhibition in BRCA-mutated metastatic cholangiocarcinoma: case report. J Gastrointest Oncol, 14(6), 2637-2643. (Read full article)
    2. Nevala-Plagemann C, Sama S, Ying J, Shen J, Haaland B, Florou V, Garrido-Laguna I (2022). A Real-World Comparison of Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer in the United States. J Natl Compr Canc Netw, 21(3), 257-264. (Read full article)
    3. Sama S, Kerrigan K, Sinnott JA, Puri S, Akerley W, Haaland B, Patel S (2023). Real-world comparison of survival outcomes with cisplatin versus carboplatin in patients with limited-stage small-cell lung cancer. Cancer Treat Res Commun, 35, 100686. (Read full article)
    4. Lopetegui Lia N, Luke A, Asad SD, Sama S, Wolansky LJ, Hegde UP (2020). Intracranial bleeding following soccer-related head trauma in a young student with occult factor VII deficiency. Clin Case Rep, 8(11), 2148-2151. (Read full article)
    5. Hennessey A, Buller D, Sama S, Girard E, Clement J, Ristau BT (2019). Case report: Adenosquamous carcinoma of the prostate with greater than 20 month response to multimodal therapy. Urol Case Rep, 29, 101084. (Read full article)
    6. Lima G, Kahn A, Sama S, Savage J (2019). Aseptic Meningitis as an Immune-Related Adverse Event after Pembrolizumab. Case Rep Oncol Med, 2019, 7183747. (Read full article)
    7. Sama S, Hadfield MJ, Lopetegui Lia N, Vredenburgh J (2019). Hyperprogression in PDL1 Expressive, Recurrent Gastroesophageal-junction Adenocarcinoma After Pembrolizumab. Cureus, 11(6), e4862. (Read full article)
    8. Kethireddy N, Sama S (2019). Cerebral Sinus Venous Thrombosis in the Setting of Acute Mastoiditis. Cureus, 11(2), e4023. (Read full article)